Search
Search Funnelback University
- Refined by:
- Date: 2020
Your query has been expanded to Antonio "Vidal Puig" |u:www.enterprize.cam.ac.uk. Search for Antonio Vidal-Puig |u:www.enterprise.cam.ac.uk instead.
1 -
1 of
1
search results for Antonio Vidal-Puig |u:www.enterprise.cam.ac.uk or Antonio "Vidal Puig" |u:www.enterprize.cam.ac.uk
where 0
match all words and 1
match some words.
Results that match 1 of 2 words
-
Cambridge Enterprise licenses PARP inhibitor drug IP to Cycle…
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-licenses-parp-inhibitor-drug-ip-cycle-pharmaceuticals/
23 Oct 2020:
Antonio Benedetti, CEO of Cycle Pharmaceuticals added: “There are existing drugs that are PARP inhibitors, and there are drug candidates in the clinical pipeline that are PARP inhibitors.
23 Oct 2020:
Antonio Benedetti, CEO of Cycle Pharmaceuticals added: “There are existing drugs that are PARP inhibitors, and there are drug candidates in the clinical pipeline that are PARP inhibitors.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
- `Recent News` |u:www.conservation.cam.ac.uk (60) · moments ago
- `0000 News Featured` |u:www.citiid.cam.ac.uk (1) · moments ago
Recent searches
Your search history is empty.